
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
Air Force made critical errors during October 7 massacre, investigator says - 2
Robert Pattinson claims he's a pathological liar. What 'The Drama' star has said about his 'shtick' - 3
Step by step instructions to Contrast Lab Precious stones and Normal Jewels - 4
A definitive Manual for Picking Electric Vehicle: Decision in favor of Your Number one - 5
Dear Santa: I want Botox. Why cosmetic procedures are topping holiday wish lists.
Journalists killed by Israeli strike in southern Lebanon
NASA troubleshoots Artemis II toilet problem in otherwise smooth flight
French high-speed train slams into truck, killing TGV driver
Role reversal: Ukraine moves training home and exports the lessons abroad
Find the Standards of Viable Nurturing: Supporting Blissful and Strong Kids
How does spider venom damage human cells? Researchers uncover the killer mechanism of recluse spider toxin
Vote in favor of your Favored kind of footwear
Artemis moon mission breaks record for distance from Earth
Displaced Palestinian families suffer as heavy rains flood Gaza tent camps













